cdmo.directory
← Compare landing

Boston Institute of Biotechnology, LLC vs Yapan Bio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bostonbib/yapan-bio

CategoryBoston Institute of Biotechnology, LLCYapan Bio
Listed sitecdmocdmo
SummaryFull-service CDMO offering cGMP and non-GMP mammalian, microbial, gene therapy, and cell therapy manufacturing from preclinical to commercial scale, with bioreactor capacity up to 50,000L.Yapan Bio provides integrated process development, characterization, and GMP manufacturing for vaccines, monoclonal antibodies, gene therapy, and viral vector-based biologics, with capabilities up to 1000L bioreactor scale and BSL-2+ containment.
Services
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Upstream Processing
  • Downstream Processing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Microbial Fermentation
  • Vaccine Manufacturing
  • AAV Manufacturing
  • Viral Vector Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Prefilled Syringe (PFS) Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Process Development
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Vaccine Manufacturing
  • Viral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Lyophilization (Freeze Drying)
  • Vial Filling
  • Microbial Fermentation
  • Recombinant Protein Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Gene Therapy
  • Cell Therapy
  • Peptide
  • AAV / Viral Vector Platform
  • Vaccine
  • Biologics (Monoclonal Antibodies)
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
IndicationsData not yet provided.Data not yet provided.
Locations
  • Southborough, Southborough, Massachusetts, United States
  • Zhangjiang (P01), Shanghai, Shanghai, China
  • Lingang (IP02), Shanghai, Shanghai, China
  • Lingang (IP03), Shanghai, Shanghai, China
  • Headquarters, Southborough, Massachusetts, United States
  • 450 GMP Facility, Hyderabad, Telangana, India
  • Process Development Facility, Hyderabad, Telangana, India
  • 270 GMP Facility, Hyderabad, Telangana, India
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.